Lynx1 Capital Management LP Insider Trading Activity
Lynx1 Capital Management LP, an institutional filer, recorded 16 transactions over the last 12 months across 5 companies totaling $17.0M.
Activity concentrated in CGEM with 8 filings. The largest single transaction was a purchase of CGEM for $4.2M on Oct 9, 2025.
Performance Scorecard
Forward stock performance after each transaction by Lynx1 Capital Management LP. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | +18.3% | — | 89% | 19 |
| 90 days | +36.7% | — | 95% | 19 |
| 120 days | +65.0% | — | 94% | 18 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Lynx1 Capital Management LP bought and sold CGEM.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 31, 2026 | KRRO | Buy | 520 | $10.60 | $6K | +0.0% | 10%+ Owner | |
Dec 23, 2025 | TCRX | Buy | 6,232 | $0.90 | $6K | +0.1% | 10%+ Owner | |
Dec 22, 2025 | TCRX | Buy | 75,500 | $0.90 | $68K | +1.0% | 10%+ Owner | |
Dec 19, 2025 | TCRX | Buy | 80,069 | $0.90 | $72K | +1.0% | 10%+ Owner | |
Oct 28, 2025 | CGEM | Buy | 165,667 | $8.40 | $1.4M | +1.9% | 10%+ Owner | |
Oct 21, 2025 | NEUP | Buy | 639,110 | $5.14 | $3.3M | +270.6% | 10%+ Owner | |
Oct 17, 2025 | CGEM | Buy | 32,217 | $7.84 | $253K | +0.4% | 10%+ Owner | |
Oct 16, 2025 Filed 3d late | CGEM | Buy | 150,000 | $8.86 | $1.3M | +1.7% | 10%+ Owner | |
Oct 15, 2025 Filed 4d late | CGEM | Buy | 51,500 | $7.94 | $409K | +0.6% | 10%+ Owner | |
Oct 14, 2025 Filed 5d late | CGEM | Buy | 15,032 | $7.59 | $114K | +0.2% | 10%+ Owner | |
Oct 10, 2025 | CGEM | Buy | 277,298 | $7.36 | $2.0M | +3.4% | 10%+ Owner | |
Oct 9, 2025 | CGEM | Buy | 626,043 | $6.70 | $4.2M | +8.2% | 10%+ Owner | |
Oct 8, 2025 | CGEM | Buy | 556,300 | $6.46 | $3.6M | +7.8% | 10%+ Owner | |
Sep 15, 2025 | PASG | Buy | 11,900 | $6.99 | $83K | +1.9% | 10%+ Owner | |
Sep 12, 2025 | PASG | Buy | 19,783 | $6.99 | $138K | +3.3% | 10%+ Owner | |
Sep 11, 2025 | PASG | Buy | 325 | $6.96 | $2K | +0.1% | 10%+ Owner | |
Jul 24, 2025 | PASG | Buy | 66,423 | $5.71 | $379K | +12.6% | 10%+ Owner | |
Jul 23, 2025 | PASG | Buy | 49,302 | $5.74 | $283K | +10.4% | 10%+ Owner | |
Jul 22, 2025 | PASG | Buy | 13,123 | $5.44 | $71K | +2.8% | 10%+ Owner |
Top Companies Traded
Other insiders at Cullinan Therapeutics, Inc.
4 other tracked filers at CGEM.